ArticleScientific reports2025
Identification and validation of inflammatory response genes linking chronic kidney disease with coronary artery disease based on bioinformatics and machine learning.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- From kidney injury to cardiac dysfunction: the central role of oxidative stress in diabetes and CKD.Basic research in cardiology · 2026Article
- Enhanced early chronic kidney disease prediction using hybrid waterwheel plant algorithm for deep neural network optimization.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Coronary artery disease (CAD) commonly occurs and elevates the risk of cardiovascular events and mortality in chronic kidney disease (CKD) patients. The underlying pathogenesis of CKD-related CAD is believed to be closely linked to inflammatory responses. Here, we explored inflammation-related markers for early diagnosis and management of CAD in CKD patients. Through comprehensive bioinformatics analysis and machine learning techniques, glutamate cysteine ligase modifier subunit (GCLM), nuclear protein 1 (NUPR1), and prostaglandin E receptor 1 (PTGER1) were selected as hub biomarkers. Furthermore, GCLM and NUPR1 were demonstrated significantly upregulated in the two validation cohorts of CKD patients with or without hemodialysis, while the change in PTGER1 was not prominent. Additionally, GCLM and NUPR1 were identified as promising indicators to predict CAD in CKD patients. Our study deciphered the higher predictive genes for CAD associated with CKD that is related to inflammation, which provides novel insights into the diagnosis and therapeutic options.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.